RedRidge Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series A
- Investors
-
4
RedRidge Bio General Information
Description
Developer of biparatopic antibody therapies designed to enhance efficacy in treating cancer and autoimmune diseases. The company offers precision-engineered antibodies that target two distinct sites on a single protein, enabling healthcare providers to achieve functional inhibition, efficient internalization, and tailored immune modulation for improved patient outcomes.
Contact Information
Website
www.redridgebio.comCorporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
Corporate Office
- Aeschenvorstadt 36
- 4051 Basel
- Switzerland
RedRidge Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 12-Mar-2025 | Completed | Startup | |||
| 1. Early Stage VC | 03-Aug-2022 | Completed | Startup |
RedRidge Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RedRidge Bio Patents
RedRidge Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026052582-A1 | Biparatopic antibodies that specifically bind fms related receptor tyrosine kinase 3 | Pending | 04-Sep-2024 |
RedRidge Bio Signals
RedRidge Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IDG Capital | Venture Capital | Minority | ||
| Laboratoires Pierre Fabre | Corporation | Minority | ||
| Sixty Degree Capital | Venture Capital | Minority | ||
| New Enterprise Associates | Venture Capital | Minority |
RedRidge Bio FAQs
-
When was RedRidge Bio founded?
RedRidge Bio was founded in 2021.
-
Where is RedRidge Bio headquartered?
RedRidge Bio is headquartered in Basel, Switzerland.
-
What is the size of RedRidge Bio?
RedRidge Bio has 22 total employees.
-
What industry is RedRidge Bio in?
RedRidge Bio’s primary industry is Drug Discovery.
-
Is RedRidge Bio a private or public company?
RedRidge Bio is a Private company.
-
What is RedRidge Bio’s current revenue?
The current revenue for RedRidge Bio is .
-
How much funding has RedRidge Bio raised over time?
RedRidge Bio has raised $4.13M.
-
Who are RedRidge Bio’s investors?
IDG Capital, Laboratoires Pierre Fabre, Sixty Degree Capital, and New Enterprise Associates have invested in RedRidge Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process